Hepatic contribution to a marked increase in the plasma concentration of baicalin after oral administration of its aglycone, baicalein, in multidrug resistance-associated protein 2-deficient rat

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 12, 2009, Pages 2079-2082

  Akao, Teruaki ^a   Sato, Keisuke ^a   Hanada, Masato ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Baicalin; Disposition; Multidrug resistance associated protein 2; Rat

Indexed keywords

BAICALEIN; BAICALIN; MULTIDRUG RESISTANCE PROTEIN 2;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DRUG DISPOSITION; HYPERBILIRUBINEMIA; LIVER SINUSOID; MALE; NONHUMAN; PORTAL VEIN; RAT; SPRAGUE DAWLEY RAT; SYSTEMIC CIRCULATION; WILD TYPE;

ANIMALS; AREA UNDER CURVE; BILIARY TRACT; FLAVANONES; FLAVONOIDS; INJECTIONS, INTRAVENOUS; LIVER; MALE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 73449105433     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.2079     Document Type: Article

References (21)

1. Koda A., Nagai H., Wada H., Nippon Yakurigaku Zasshi, 66, 237-247 (1970).
2. Kubo M., Matsuda H., Tanaka M., Kimura Y., Okuda H., Higashino M., Tani T., Namba K., Arichi S., Chem. Pharm. Bull., 32, 2724-2729 (1984).
3. Baylor N. W., Fu T., Yan Y. D., Ruscetti F. W., J. Infect. Dis., 165, 433-437 (1992).
4. Li B. Q., Fu T., Yao D. Y., Mikovits J. A., Ruscetti F. W., Wang J. M., Biochem. Biophys. Res. Commun., 276, 534-538 (2000).
5. Inoue T., Jackson E. K., Eur. J. Pharmacol., 378, 129-135 (1999).
6. Motoo Y., Sawabu N., Cancer Lett., 86, 91-95 (1994).
7. Kimura Y., Kubo M., Tani T., Arichi S., Okuda H., Chem. Pharm. Bull., 29, 2610-2617 (1981).
8. Gao Z., Huang K., Yang X., Xu H., Biochim. Biophys. Acta, 1472, 643-650 (1999).
9. Chen Y. C., Shen S. C., Chen L. G., Lee T. J., Yang L. L., Biochem. Pharmacol., 61, 1417-1427 (2001).
10. Liao J. F., Hung W. Y., Chen C. F., Eur. J. Pharmacol., 464, 141-146 (2003).
11. Wang S. Y., Wang H. H., Chi C. W., Chen C. F., Liao J. F., Eur. J. Pharmacol., 506, 55-61 (2004).
12. Wakui Y., Yanagisawa E., Ishibashi E., Matsuzaki Y., Takeda S., Sasaki H., Aburada M., Oyama T., J. Chromatogr., 575, 131-136 (1992).
13. Akao T., Kawabata K., Yanagisawa E., Ishihara K., Mizuhara Y., Wakui Y., Sakashita Y., Kobashi K., J. Pharm. Pharmacol., 52, 1563-1568 (2000).
14. Akao T., Sakashita Y., Hanada M., Goto H., Shimada Y., Terasawa K., Pharm. Res., 21, 2120-2126 (2004).
15. Keppler D., Konig J., FASEB J., 11, 509-516 (1997).
16. Sasa H., Hashimoto Y., Shimizu T., Inui K., Biol. Pharm. Bull., 21, 610-614 (1998).
17. Takikawa H., Sano N., Narita T., Uchida Y., Yamanaka M., Horie T., Mikami T., Tagaya O., Hepatology, 14, 352-360 (1991).
18. Suzuki H., Sugiyama Y., Adv. Drug Deliv. Rev., 54, 1311-1331 (2002).
19. Ito K., Suzuki H., Horie T., Sugiyama Y., Pharm. Res., 22, 1559-1577 (2005).
20. Akao T., Hanada M., Y., Sakashita Y., Sato K., Morita M., Imanaka T., J. Pharm. Pharmacol., 59, 87-93 (2007).
21. Uchida E., Fukasawa I., Matsuzaki Y., Inagaki M., Uchida N., Takeda S., Wakui Y., Tsuchiya T., Yasuhara H., Oguchi K., Jpn. Pharmacol. Ther., 23, 659-670 (1995).